HD causes cognitive, behavioral, and physical challenges, including involuntary movements known as HD chorea, which can disrupt daily life
Generic Saxenda is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the US market
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings
She brings extensive expertise in managing global and domestic procurement operations
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
The agreement could rise to $900 million if key commercial milestones are met
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
